Le Lézard
Classified in: Science and technology
Subjects: AWD, VET

Veterans Guardian Honored with 2024 Military Friendly Gold Employer Award


PINEHURST, N.C., Nov. 13, 2023 /PRNewswire/ -- Veterans Guardian VA Claim Consulting received the 2024 Gold Military Friendly Employer by VIQTORY. Military Friendly is the standard that measures an organization's commitment, effort, and success in creating sustainable and meaningful benefits for the military community. This is the fourth year Veterans Guardian has been awarded a Military Friendly Employer Award recognition for their veteran recruitment and employment efforts.

VIQTORY is a service-disabled, veteran-owned small business (SDVOSB) that connects the military community to civilian employment, educational, and entrepreneurial opportunities. Over 2,100 organizations compete annually for a Military Friendly designation. This year, Veterans Guardian received a gold designation.

"As a veteran-owned and operated company, we are honored to receive the Military Friendly Gold Employer Award," said Scott Greenblatt, CEO and Founder of Veterans Guardian. "The foundation of Veterans Guardian is built on the commitment, dedication, and passion of our veteran staff members."

Apart from their veteran recruitment, Veterans Guardian is committed to paying tribute to military veterans and their families by engaging in diverse community outreach efforts, advocating for their rights, and providing continuous financial assistance to veteran and community-focused charities, scholarship programs, and organizations.

"Organizations earning the Military Friendly Employers designation have invested in comprehensive and impactful initiatives that bring about positive results for our valued service members and esteemed veterans," said Kalya Lopex, Senior Director of Military Partnerships at Military Friendly. "We salute these exemplary employers who raise the bar and understand that hiring military personnel is not merely an act of goodwill but a testament to a standard that embodies sound business wisdom."

About Veterans Guardian

Veterans Guardian is a VA Claim Consulting Firm headquartered in Pinehurst, NC, serving clients worldwide.  Veterans Guardian works to help Veterans attain the VA Disability benefits they are medically and ethically eligible for as a result of their honorable service in the United States Military. For more information, visit www.VetsGuardian.com

SOURCE Veterans Guardian


These press releases may also interest you

at 06:00
BioInvent and Transgene's Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase 1/2a Trial in Solid Tumors that Failed Previous Treatments
BioInvent International (STO:BINV)Preliminary data presented at ESMO 2024 demonstrate BT-001 induces tumor regression in patients who failed previous anti-PD(L)-1 treatmentIn a patient with a heavily pretreated leiomyosarcoma, BT-001 was able to...

at 05:18
Mox Capital Announces Strategic Support for Rapid-Scaling Startups Across Vietnam and Southeast Asia
Mox Capital, a trailblazer in alternative investments with AUM of US$1.4 billion, is announcing its strategic support for a vast array and variety of regional high-potential startups. According to COO Nguyen Dinh Giang, Mox Capital seeks to reinforce...

at 05:00
Nuvalent Highlights Presentation of Clinical Data at ESMO 2024 for Parallel Lead Programs for ROS1 and ALK-positive NSCLC and Accelerated Development Timelines
Updated Phase 1 dose-escalation data from ARROS-1 and ALKOVE-1 clinical trials continue to support potential best-in-class profiles for zidesamtinib and NVL-655 Rapid enrollment in Phase 2 portions of the ARROS-1 and ALKOVE-1 clinical trials;...

at 04:20
Pfizer's BRAFTOVI® + MEKTOVI® Shows Long-Term Clinically Meaningful Response in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
Pfizer Inc. today announced longer-term follow-up results from the Phase 2 single-arm PHAROS clinical trial evaluating the efficacy and safety of BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for patients with BRAF V600E-mutant...

at 04:06
Harbour BioMed Announces the Latest Clinical Data on the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024
Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology, announced the latest clinical data on...

at 04:05
Irdeto Partners with Bitmovin to Deliver Industry-Leading Secure Low-Latency Streaming with Unmatched User Experience
Irdeto, the global leader in digital video platform experiences and security, and Bitmovin, the industry leader in video software solutions, today announced a strategic partnership to deliver enhanced secure video streaming experiences. This...

More news about Science and technology...


News published on and distributed by: